Project Profile:A cosmetics trader sells a suit of fibre-stereotyped products and co-sprayed cosmetics. The two products are independently packaged and have different components. Clients have previously submitted MoCRA-related information through other service providers, but have not been cleared through cross-border power provider platforms. The original audit opinion given by the Platform was that the declaration was not consistent with the product label information.

Package sales do not amount to two products of different formulations being treated as one product.At the same time, the project needs to check the composition and names of the production facilities, brands, companies listed on the labels, those responsible and each product.

What's wrong with the original data?

The labels provided by the client labeled the factory information, whereas the earlier MoCRA declarations used traders information, which was not matched. The original service provider also treats the increased hair and the styrofoam as a whole package without presenting two separate packages of products with different components. ALREG first returns the cross-border power provider platform to identify specific fields that need to be revised by contrasting the label with the original declaration item.

How to check factory and brand information?

  1. Communicate with the actual production plant and confirm the registration of its facilities and branding of the products produced.
  2. Assists in adding customer brand information to the plant’s corresponding MoCRA facility registration and in checking the responsible persons ' information against the companies listed in the label.
  3. (b) Re-check the labels of the two products and check whether the product name, the subject matter, the composition and the declaration are consistent with the information to be submitted.

The information on the registration of the FDA facility contains the brand name of the facility produced or processed and the corresponding names of the responsible persons on the labels of the various brands; product listing also requires the submission of responsible person and product names consistent with the label. The simple replacement of trader information with factory information solves all problems and still needs to be identified on a case-by-case basis by actual labels and corporate roles.

What about the two products in the suit?

Fibre-type products are separately packaged separately from the components of the combustible cosmetics. The team collates the names, categories, components, responsible persons and production facilities of the two products and reprocesses them accordingly. The package sales page of the cross-border power provider platform is a combination of sales, but cannot substitute for the FDA listing information applicable to the products in the package.

FDA allows multiple cosmetics with identical formulations, or only different colours, fragrances, tastes and net content, to be combined in one listing submission; This allowed scope cannot be applied directly to products with different components in the present case.

Results of the project and applicable boundaries

Client feedback, information and label adjustments have been completed and the product has been installed on a cross-border power provider platform. The platform’s top shelf is the result of a review of client feedback that does not represent FDA approval of products, nor does it imply that all cosmetics kits need to be listed in the same way. Whether products are cosmetics should also be judged against the actual uses and claims in labelling and publicity.

Checklist for similar package items

  • Retain the Platform’s return of views, overpacking and separate labels for each product.
  • The formulation, composition, name, purpose and sale of each product are organized separately and the listing is judged.
  • Checking the matching relationships in manufacturing facilities, brands, label dutyrs and product listing.
  • Check the website and platform files to see if there are any claims, such as “breeding” , that could change the product regulatory classification.

Official sources and reconciliation dates

Source: Project description provided by the client to All Reg and cross-border power provider platform review recapitulation; Clients, brands, factories and product numbers have been anonymous. First-time publication and reconciliation of regulatory information: 2026-10-29. Cross-border power provider platforms are mounted as client feedback and do not amount to FDA approval or certification of products.

Consult with MoCRA for information on declarationsView pricing and order online ↗ View cosmetics FDA compliance service